Emergence of amoxicillin-resistant variants of Spain9V-ST156 pneumococci expressing serotype 11A correlates with their ability to evade the host immune response

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Aguinagalde, Leire ^a   Corsini, Bruno ^a   Domenech, Arnau ^b,c   Domenech, Mirian ^c,d   Cámara, Jordi ^b,c   Ardanuy, Carmen ^b,c   García, Ernesto ^c,d   Liñares, Josefina ^b,c   Fenoll, Asunción ^a   Yuste, Jose ^a,c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AUTOLYSIN; BETA LACTAM DERIVATIVE; CEFOTAXIME; CEFTRIAXONE; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; COMPLEMENT FACTOR H; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; BACTERIAL PROTEIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BIOFILM; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN CELL; IMMUNE EVASION; IMMUNE RESPONSE; MOLECULAR TYPING; NEUTROPHIL; NONHUMAN; OPSONIZATION; PENICILLIN RESISTANCE; PHAGOCYTOSIS; SEROTYPE; SPAIN; STREPTOCOCCUS PNEUMONIAE; ADOLESCENT; ADULT; BIOSYNTHESIS; CHILD; CLINICAL TRIAL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HISTORY; HL-60 CELL LINE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AMOXICILLIN; BACTERIAL PROTEINS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GENOTYPE; HISTORY, ANCIENT; HL-60 CELLS; HUMANS; IMMUNE EVASION; MALE; PNEUMOCOCCAL VACCINES; SEROGROUP; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 84947441574     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137565     Document Type: Article

References (42)

1. O'Brien KL, Levine OS. Effectiveness of pneumococcal conjugate vaccine. Lancet. 2006; 368: 1469-1470. PMID: 17071264
2. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009; 374: 893-902. doi: 10.1016/S0140-6736(09)61204-6 PMID: 19748398
3. Park IH, Geno KA, Yu J, Oliver MB, Kim K-H, Nahm MH. Genetic, biochemical, and serological characterization of a new pneumococcal serotype, 6H, and generation of a pneumococcal strain producing three different capsular repeat units. Clin Vaccine Immunol. 2015; 22: 313-318 doi: 10.1128/CVI. 00647-14 PMID: 25589550
4. Brueggemann AB, Spratt BG. Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates. J Clin Microbiol. 2003; 41: 4966-4970. PMID: 14605125
5. Tarragó D, Aguilar L, García R, Gimenez M-J, Granizo J-J, Fenoll A. Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008. Antimicrob Agents Chemother. 2011; 55: 2297-2302. doi: 10.1128/AAC.01494-10 PMID: 21343456
6. Ardanuy C, Tubau F, Pallares R, Calatayud L, Domínguez MA, Rolo D, et al. Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin Infect Dis. 2009; 48: 57-64. doi: 10.1086/ 594125 PMID: 19035779
7. Brueggemann AB, Pai R, Crook DW, Beall B. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog. 2007; 3: e168. PMID: 18020702
8. Golubchik T, Brueggemann AB, Street T, Gertz RE Jr, Spencer CCA, Ho T, et al. Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event. Nat Genet. 2012; 44: 352-355. doi: 10.1038/ng.1072 PMID: 22286217
9. Coffey TJ, Dowson CG, Daniels M, Zhou J, Martin C, Spratt BG, et al. Horizontal transfer of multiple penicillin-binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae. Mol Microbiol. 1991; 5: 2255-2260. PMID: 1766389
10. Kadioglu A, Weiser JN, Paton JC, Andrew PW. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol. 2008; 6: 288-301. doi: 10.1038/ nrmicro1871 PMID: 18340341
11. van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet. 2009; 374: 1543-1556. doi: 10.1016/S0140-6736(09)61114-4 PMID: 19880020
12. Walport MJ. Complement. First of two parts. N Engl J Med. 2001; 344: 1058-1066. PMID: 11287977
13. Brown JS, Hussell T, Gilliland SM, Holden DW, Paton JC, Ehrenstein MR, et al. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci U S A. 2002; 99: 16969-16974. PMID: 12477926
14. Yuste J, Sen A, Truedsson L, Jönsson G, Tay L-S, Hyams C, et al. Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway. Infect Immun. 2008; 76: 3761-3770. doi: 10.1128/IAI.00291-08 PMID: 18541650
15. Domenech M, Ramos-Sevillano E, García E, Moscoso M, Yuste J. Biofilm formation avoids complement immunity and phagocytosis of Streptococcus pneumoniae. Infect Immun. 2013; 81: 2606-2615. doi: 10.1128/IAI.00491-13 PMID: 23649097
16. Domenech M, Araújo-Bazán L, García E, Moscoso M. In vitro biofilm formation by Streptococcus pneumoniae as a predictor of post-vaccination emerging serotypes colonizing the human nasopharynx. Environ Microbiol. 2014; 16: 1193-1201. doi: 10.1111/1462-2920.12370 PMID: 24373136
17. de la Campa AG, Ardanuy C, Balsalobre L, Pérez-Trallero E, Marimón JM, Fenoll A, et al. Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain. Emerg Infect Dis. 2009; 15: 905-911. doi: 10.3201/eid1506.080684 PMID: 19523289
18. Farrell DJ, Jenkins SG, Brown SD, Patel M, Lavin BS, Klugman KP. Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Emerg Infect Dis. 2005; 11: 851-858. PMID: 15963279
19. Sanz JC, Cercenado E, Marín M, Ramos B, Ardanuy C, Rodríguez-Avial I, et al. Multidrug-resistant pneumococci (serotype 8) causing invasive disease in HIV+ patients. Clin Microbiol Infect. 2011; 17: 1094-1098. doi: 10.1111/j.1469-0691.2011.03495.x PMID: 21463396
20. Ardanuy C, de la Campa AG, Garcia E, Fenoll A, Calatayud L, Cercenado E, et al. Spread of Streptococcus pneumoniae serotype 8-ST63 multidrug-resistant recombinant clone, Spain. Emerg Infect Dis, 2014; 20: 1848-1856. doi: 10.3201/eid2011.131215 PMID: 25340616
21. Coffey TJ, Dowson CG, Daniels M, Spratt BG. Genetics and molecular biology of β-lactam-resistant pneumococci. Microb Drug Resist. 1995; 1: 29-34. PMID: 9156381
22. Fenoll A, Granizo JJ, Aguilar L, Giménez MJ, Aragoneses-Fenoll L, Hanquet G, et al. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol. 2009; 47: 1012-1020. doi: 10.1128/JCM.01454-08 PMID: 19225097
23. Fenoll A, Jado I, Vicioso D, Casal J. Dot blot assay for the serotyping of pneumococci. J Clin Microbiol. 1997; 35: 764-766. PMID: 9041430
24. Tarragó D, Fenoll A, Sánchez-Tatay D, Arroyo LA, Muñoz-Almagro C, Esteva C, et al. Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR. Clin Microbiol Infect. 2008; 14: 828-834. doi: 10.1111/j.1469-0691.2008.02028.x PMID: 18844683
25. Enright MC, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology. 1998; 144: 3049-3060. PMID: 9846740
26. Ramos-Sevillano E, Urzainqui A, Campuzano S, Moscoso M, González-Camacho F, Domenech M, et al. Pleiotropic effects of the cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response. Infect Immun. 2015; 83: 591-603. doi: 10.1128/IAI.02811-14 PMID: 25404032
27. Ramos-Sevillano E, Moscoso M, García P, García E, Yuste J. Nasopharyngeal colonization and invasive disease are enhanced by the cell wall hydrolases LytB and LytC of Streptococcus pneumoniae. PLoS One. 2011; 6: e23626. doi: 10.1371/journal.pone.0023626 PMID: 21886805
28. Romero-Steiner S, Libutti D, Pais LB, Dykes J, Anderson P, Whitin JC, et al. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol. 1997; 4: 415-422. PMID: 9220157
29. Moscoso M, García E, López R. Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. J Bacteriol. 2006; 188: 7785-7795. PMID: 16936041
30. Lambris JD, Ricklin D, Geisbrecht BV. Complement evasion by human pathogens. Nat Rev Microbiol. 2008; 6: 132-142. doi: 10.1038/nrmicro1824 PMID: 18197169
31. Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, et al. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med. 2013; 10: e1001517. doi: 10.1371/journal.pmed.1001517 PMID: 24086113
32. Porat N, Arguedas A, Spratt BG, Trefler R, Brilla E, Loaiza C, et al. Emergence of penicillin-nonsusceptible Streptococcus pneumoniae clones expressing serotypes not present in the antipneumococcal conjugate vaccine. J Infect Dis. 2004; 190: 2154-2161. PMID: 15551214
33. Gounder PP, Bruce MG, Bruden DJ, Singleton RJ, Rudolph K, Hurlbult DA, et al. Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae- Alaska, 2008-2012. J Infect Dis. 2014; 209: 1251-1258. doi: 10.1093/infdis/jit642 PMID: 24273178
34. Scott JR, Hanage WP, Lipsitch M, Millar EV, Moulton LH, Hinds J, et al. Pneumococcal sequence type replacement among American Indian children: a comparison of pre- and routine-PCV7 eras. Vaccine. 2012; 30: 2376-2381. doi: 10.1016/j.vaccine.2011.11.004 PMID: 22094283
35. Sjöström K, Blomberg C, Fernebro J, Dagerhamn J, Morfeldt E, Barocchi MA, et al. Clonal success of piliated penicillin nonsusceptible pneumococci. Proc Natl Acad Sci U S A. 2007; 104: 12907-12912. PMID: 17644611
36. Henriques-Normark B, Blomberg C, Dagerhamn J, Battig P, Normark S. The rise and fall of bacterial clones: Streptococcus pneumoniae. Nat Rev Microbiol. 2008; 6: 827-837. doi: 10.1038/nrmicro2011 PMID: 18923410
37. Hanage WP, Kaijalainen TH, Syrjänen RK, Auranen K, Leinonen M, Mäkelä PH, et al. Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect Immun. 2005; 73: 431-435. PMID: 15618181
38. Stanhope MJ, Lefébure T, Walsh SL, Becker JA, Lang P, Pabinski Bitar PD, et al. Positive selection in penicillin-binding proteins 1a, 2b, and 2x from Streptococcus pneumoniae and its correlation with amoxicillin resistance development. Infect Genet Evol. 2008; 8: 331-339. doi: 10.1016/j.meegid.2008. 02.001 PMID: 18394970
39. Schulz zur Wiesch P, Engelstädter J, Bonhoeffer S. Compensation of fitness costs and reversibility of antibiotic resistance mutations. Antimicrob Agents Chemother. 2010; 54: 2085-2095. doi: 10.1128/ AAC.01460-09 PMID: 20176903
40. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002; 15: 167-193. PMID: 11932229
41. Domenech M, Damián D, Ardanuy C, Liñares J, Fenoll A, García E. Emerging, non-PCV13 serotypes 11A and 35B of Streptococcus pneumoniae show high potential for biofilm formation in vitro. PLoS One. 2015; 10: e0125636. doi: 10.1371/journal.pone.0125636 PMID: 25927917
42. Yuste J, Khandavilli S, Ansari N, Muttardi K, Ismail L, Hyams C, et al. The effects of PspC on complement- mediated immunity to Streptococcus pneumoniae vary with strain background and capsular serotype. Infect Immun. 2010; 78: 283-292. doi: 10.1128/IAI.00541-09 PMID: 19884335